MA38878B1 -
Novel 3-chloro-3-fluoro-tetrahydro-furan compounds inhibiting hepatitis c virus polymerase, useful for the treatment or prophylaxis of hepatitis c virus infection.
- Google Patents
Novel 3-chloro-3-fluoro-tetrahydro-furan compounds inhibiting hepatitis c virus polymerase, useful for the treatment or prophylaxis of hepatitis c virus infection.
Info
Publication number
MA38878B1
MA38878B1MA38878AMA38878AMA38878B1MA 38878 B1MA38878 B1MA 38878B1MA 38878 AMA38878 AMA 38878AMA 38878 AMA38878 AMA 38878AMA 38878 B1MA38878 B1MA 38878B1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir AbfiledCriticalMedivir Ab
Priority claimed from PCT/SE2014/051005external-prioritypatent/WO2015034420A1/en
Publication of MA38878A1publicationCriticalpatent/MA38878A1/en
Publication of MA38878B1publicationCriticalpatent/MA38878B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La présente invention concerne des composés de formule : (i) dans laquelle b représente une nucléobase choisie parmi les groupes (a) à (d) et les autres variables sont telles que définies dans les revendications, lesdits composés étant destinés à être utilisés dans le traitement ou la prophylaxie d'une infection par le virus de l'hépatite c, et des aspects associés.The present invention relates to compounds of formula: (i) wherein b represents a nucleobase selected from groups (a) to (d) and the other variables are as defined in the claims, said compounds being for use in the treatment or prophylaxis of hepatitis c virus infection, and related aspects.
MA38878A2013-09-042014-09-02
Novel 3-chloro-3-fluoro-tetrahydro-furan compounds inhibiting hepatitis c virus polymerase, useful for the treatment or prophylaxis of hepatitis c virus infection.
MA38878B1
(en)
Novel 3-chloro-3-fluoro-tetrahydro-furan compounds inhibiting hepatitis c virus polymerase, useful for the treatment or prophylaxis of hepatitis c virus infection.